Zhejiang Tianyu Pharmaceutical
Taizhou, Zhejiang, China
Hybrid — also manufactures internal programs
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (1)
○ EMA GMP
○ MHRA GMP
✓ HC GMP (3)
Quick Facts: Zhejiang Tianyu Pharmaceutical
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Taizhou, Zhejiang, China
- Website
- http://en.tianyupharm.com/cdmo.html
- Modalities
- Small Molecule API, Intermediates, Custom Synthesis, High-Potency APIs, Spray Drying
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Zhejiang Tianyu Pharmaceutical
Zhejiang Tianyu Pharmaceutical makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Small Molecule API, Intermediates, Custom Synthesis, High-Potency APIs, Spray Drying. 1 manufacturing site registered with the U.S. FDA and Health Canada. Website: http://en.tianyupharm.com/cdmo.html
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 30, 2026
Company Signals 1 articles
Company announcements, not verified evidence. They do not change any score.
Tranche Update on Zhejiang Tianyu Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 10, 2026. - www.marketscreener.com
Tranche Update on Zhejiang Tianyu Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 10, 2026. www.marketscreener.com
Frequently Asked Questions About Zhejiang Tianyu Pharmaceutical
Does Zhejiang Tianyu Pharmaceutical have a CDMO Signal Score?
Not yet. Zhejiang Tianyu Pharmaceutical is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Zhejiang Tianyu Pharmaceutical for a manufacturing program?
Use the free AI matchmaker to compare Zhejiang Tianyu Pharmaceutical against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
Axplora
Paris, France
Small Molecule API, Intermediates, High-Potency APIs, Custom Synthesis
Yuhan Chemical
Ansan, Gyeonggi-do, South Korea
Small Molecule API, Intermediates, High-Potency APIs, Custom Synthesis
Jiangxi Fushine Pharmaceutical
Jingdezhen, Jiangxi, China
Small Molecule API, Intermediates, Custom Synthesis
Zenji Pharmaceuticals
Huai'an, Jiangsu, China
Small Molecule API, Intermediates, Custom Synthesis, Oral Solid Dose
Zhejiang Yongtai Technology
Linhai, Zhejiang, China
Intermediates, Small Molecule API, Custom Synthesis
Compare Zhejiang Tianyu Pharmaceutical with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.